Skip to content
Dose Brief
Menu

AM Rx review

By Updated

AM Rx advertises semaglutide from $106 a month on a quarterly purchase. Its policy separately describes membership fees.

Brief Score39/100Grade CNo. 545 in our directory
Visit AM Rx View the provider’s current plans and terms.

On the record

The FDA issued a warning letter to FitRX, LLC dba AM RX in June 2026. Read the letter in the FDA's warning letter database for the agency's findings.

Semaglutide

Advertised from $106/mo when purchased quarterly. Confirm fees.

Tirzepatide

Request a plan-specific quote.

Coverage
Confirm availability with AM Rx for the selected treatment.
Brand-name
Yes
On the trackerNewnew to the tracker, no prior reading— Ask for the full quarterly charge and separate membership fees.

AM Rx in depth

Get the full AM Rx bill

AM Rx advertises semaglutide from $106 a month when purchased quarterly. Use the billing guide to compare the checkout amount and supply with other plans. AM Rx’s policy describes a membership fee as well as possible prescription and other service charges.

Check which charges can be stopped

Members are told to cancel through Manage Membership before renewal. Eden, by comparison, advertises its compounded GLP-1 program at a recurring monthly price without a separate membership fee. If you are stopping a subscription, ask whether a prescription has already been filled and save the confirmation. The policy treats filled prescriptions as final and describes consultation and membership fees as nonrefundable.

Verify the brand-name pathway

AM Rx also lists an insurance pathway for certain brands. When checking coverage, ask about the exact drug, network pharmacy and any authorization requirement before budgeting around the advertised insured price. Confirm the AM Rx program charge separately. In June 2026 the FDA warned FitRX, LLC dba AM RX about claims and images on its site that misrepresented its compounded products.

Sources we checked

Public program pages and terms, checked November 2026. We have not enrolled in treatment or independently tested the medication.

This source update covers the review text and stated program terms. The existing numerical score has not been recalculated from this check; it should not be read as a new validation of every score factor.

The scorecard

AM Rx scored on our six Brief Score factors. See the methodology.

Price Stability32/100
Supply Reliability59/100
Transparency24/100
Access Breadth46/100
Clinical Oversight47/100
Track Record25/100

What we like

  • Lists brand-name and compounded options
  • Publishes an account cancellation process

The caveats

  • Quarterly starting figure does not establish the complete bill
  • Filled prescriptions are final under its policy

The brief

Best for: Readers comparing a quarterly cash-pay offer with insurance assistance. AM Rx advertises semaglutide from $106 a month on a quarterly purchase. Its policy separately describes membership fees.

Ranked #545 of 546 providers we reviewed — compare with CoreAge Rx, for comparison.

Before you decide

The questions readers ask next after reading about AM Rx.

Closest here

The providers scoring nearest AM Rx — read each current assessment before choosing care.

Weighing AM Rx against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs AM Rx, and every provider that outranks it is listed on the AM Rx alternatives ranking.

More providers we track (24)

514 more are filed too — see every provider we track, ranked.

Pricing, states and verification reflect AM Rx's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on AM Rx's site. Not medical advice; see our disclosure.

← Back to all rankings